Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: In vitro and in vivo studies in rat

G. C. Ji, S. T. Zhou, G. Shapiro, J. C. Reubi, S. M. Carlton, Simona Jurczyk

    Research output: Contribution to journalArticle

    21 Scopus citations

    Abstract

    Several lines of evidence support an important role for somatostatin receptors (SSTRs) in pain modulation. The therapeutic use of established SSTR peptide agonists for this indication is limited by their broad range of effects, need for intrathecal delivery, and short half-life. Therefore, the goal of the present study was to investigate the analgesic effect of SCR007, a new, highly selective SSTR2 non-peptide agonist. Behavioral studies demonstrated that paw withdrawal latencies to heat were significantly increased following intraplantar SCR007. Furthermore, both intraperitoneal and intraplantar injection of SCR007 significantly reduced formalin- and capsaicin-induced flinching and lifting/licking nociceptive behaviors. Recordings from nociceptors using an in vitro glabrous skin-nerve preparation showed that SCR007 reduced heat responses in a dose-dependent fashion, bradykinin-induced excitation, heat sensitization and capsaicin-induced excitation. In both the behavioral and single fiber studies, the SCR007 effects were reversed by the SSTR antagonist cyclo-somatostatin, demonstrating receptor specificity. In the single fiber studies, the opioid antagonist naloxone did not reverse SCR007-induced anti-nociception suggesting that SCR007 did not exert its effects through activation of opioid receptors. Analysis of cAMP/protein kinase A (PKA) involvement demonstrated that SCR007 prevented forskolin- and Sp-8-Br-cAMPS (a PKA activator)-induced heat sensitization, supporting the hypothesis that SCR007-induced inhibition could involve a down-regulation of the cAMP/PKA pathway. These data provide several lines of evidence that the non-peptide imidazolidinedione SSTR2 agonist SCR007 is a promising anti-nociceptive and analgesic agent for the treatment of pain of peripheral and/or central origin.

    Original languageEnglish (US)
    Pages (from-to)34-49
    Number of pages16
    JournalPain
    Volume124
    Issue number1-2
    DOIs
    StatePublished - Sep 2006

    Keywords

    • Analgesia
    • Anti-nociception
    • Capsaicin
    • Inflammation
    • Inflammatory pain
    • Peripheral sensitization

    ASJC Scopus subject areas

    • Neurology
    • Clinical Neurology
    • Anesthesiology and Pain Medicine

    Fingerprint Dive into the research topics of 'Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: In vitro and in vivo studies in rat'. Together they form a unique fingerprint.

  • Cite this

    Ji, G. C., Zhou, S. T., Shapiro, G., Reubi, J. C., Carlton, S. M., & Jurczyk, S. (2006). Analgesic activity of a non-peptide imidazolidinedione somatostatin agonist: In vitro and in vivo studies in rat. Pain, 124(1-2), 34-49. https://doi.org/10.1016/j.pain.2006.03.014